Skip to main content
OpenTrials
Completed

NCT Number: NCT02404142

Curarisation and Intubation Conditions During Videolaryngoscopy With Glidescope Titanium

In this prospective, randomized study, the investigators assess the intubation conditions during videolaryngoscopy with Glidescope Titanium whether patients receive (curare (Atracurium) group) or no (control group) within elective surgery patients with no difficult intubation prediction

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Tracheal Intubation

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Chu de Reims

Reims, 51092, France

About this study

In this prospective, randomized study, the investigators assess the intubation conditions during videolaryngoscopy with Glidescope Titanium whether patients receive (curare (Atracurium)group) or no (control group) within elective surgery patients with no difficult intubation prediction. The IDS score assessed by an anesthesiologist from the video-recording is the primary outcome. All general anesthesias are standardized using Target Control Infusion of propofol and sufentanil. The investigators also compare IDS scores as assessed by intubators, time for tracheal intubation, and laryngeal morbidity in both groups.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Elective Surgery Adult Patients
  • no difficult intubation prediction

Exclusion criteria

Treatment and study plan

Curare (Atracurium)

Drug

Curare (Atracurium) versus saline isotonic solution for tracheal intubation

Saline isotonic solution

Drug

Primary outcomes

  1. IDS score video-assessed as described by Adnet et al. Measurement will be made by 2 experts anesthesiologists for centralized reading

    Time frame: Assessment will be done at the end of the inclusions period (9 months)

    Number of IDS scores <2 are compared

Secondary outcomes

  1. IDS score assesed by the intubator anesthesiologist

    Time frame: 3 days post intubation

Sponsors and collaborators

Lead sponsor

CHU de Reims

Other

Collaborators

  • Verathon

Registry information

Acronym: GICAC

Important dates

Study start
2015
Primary completion
2016
Study completion
2016
First posted
Mar 31, 2015
Registry last updated
Jan 9, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.